Ke-Da Yu1, Shuang Li, Zhi-Ming Shao. 1. Department of Breast Surgery, Fudan University Shanghai Cancer Center/Cancer Institute, Shanghai, PR China.
Abstract
PURPOSE: To investigate the recurrence pattern and annual recurrence risk after breast-conserving surgery and compare them with those after mastectomy. METHODS: This retrospective analysis included 6,135 consecutive unilateral breast cancer patients undergoing surgery in 1998-2008, with 847 lumpectomy patients and 5,288 mastectomy patients. Recurrence patterns were scrutinized and annual recurrence rates were calculated. Furthermore, a literature-based review including seven relevant studies was subsequently performed to confirm our single-institution data-based observations. RESULTS: After lumpectomy, 50.9% of recurrences occurred within 3 years and 30.2% of recurrences were detected at 3-5 years; after mastectomy, 64.9% of recurrences occurred within 3 years and 20.4% occurred at 3-5 years. The major locoregional recurrence pattern after lumpectomy was ipsilateral breast tumor recurrence, which mainly (81.3%) occurred ≤5 years postsurgery but with a low incidence of 37.5% ≤3 years postsurgery. Annual recurrence curves indicated that the relapse peak after mastectomy emerged in the first 2 years; however, recurrence after lumpectomy increased annually with the highest peak near 5 years. By reviewing relevant studies, we confirmed our finding of different annual recurrence patterns for lumpectomy and mastectomy patients. The hazard ratio of dying for those recurring ≤5 years postlumpectomy relative to patients relapsing >5 years postlumpectomy was 4.62 (95% confidence interval, 1.05-20.28; p = .042). CONCLUSIONS: Different recurrence patterns between mastectomy and lumpectomy patients imply that scheduling of surveillance visits should be more frequent during the 4-6 years after lumpectomy. Further prospective trials addressing the necessity of frequent and longer surveillance after lumpectomy are warranted.
PURPOSE: To investigate the recurrence pattern and annual recurrence risk after breast-conserving surgery and compare them with those after mastectomy. METHODS: This retrospective analysis included 6,135 consecutive unilateral breast cancerpatients undergoing surgery in 1998-2008, with 847 lumpectomy patients and 5,288 mastectomy patients. Recurrence patterns were scrutinized and annual recurrence rates were calculated. Furthermore, a literature-based review including seven relevant studies was subsequently performed to confirm our single-institution data-based observations. RESULTS: After lumpectomy, 50.9% of recurrences occurred within 3 years and 30.2% of recurrences were detected at 3-5 years; after mastectomy, 64.9% of recurrences occurred within 3 years and 20.4% occurred at 3-5 years. The major locoregional recurrence pattern after lumpectomy was ipsilateral breast tumor recurrence, which mainly (81.3%) occurred ≤5 years postsurgery but with a low incidence of 37.5% ≤3 years postsurgery. Annual recurrence curves indicated that the relapse peak after mastectomy emerged in the first 2 years; however, recurrence after lumpectomy increased annually with the highest peak near 5 years. By reviewing relevant studies, we confirmed our finding of different annual recurrence patterns for lumpectomy and mastectomy patients. The hazard ratio of dying for those recurring ≤5 years postlumpectomy relative to patients relapsing >5 years postlumpectomy was 4.62 (95% confidence interval, 1.05-20.28; p = .042). CONCLUSIONS: Different recurrence patterns between mastectomy and lumpectomy patients imply that scheduling of surveillance visits should be more frequent during the 4-6 years after lumpectomy. Further prospective trials addressing the necessity of frequent and longer surveillance after lumpectomy are warranted.
Authors: Bernard Fisher; Jong-Hyeon Jeong; Stewart Anderson; John Bryant; Edwin R Fisher; Norman Wolmark Journal: N Engl J Med Date: 2002-08-22 Impact factor: 91.245
Authors: J M Kurtz; J M Spitalier; R Amalric; H Brandone; Y Ayme; J Jacquemier; D Hans; C Bressac Journal: Int J Radiat Oncol Biol Phys Date: 1990-01 Impact factor: 7.038
Authors: A S Lichter; M E Lippman; D N Danforth; T d'Angelo; S M Steinberg; E deMoss; H D MacDonald; C M Reichert; M Merino; S M Swain Journal: J Clin Oncol Date: 1992-06 Impact factor: 44.544
Authors: A C Voogd; M Nielsen; J L Peterse; M Blichert-Toft; H Bartelink; M Overgaard; G van Tienhoven; K W Andersen; R J Sylvester; J A van Dongen Journal: J Clin Oncol Date: 2001-03-15 Impact factor: 44.544
Authors: Ke-Da Yu; Rui Zhu; Ming Zhan; Angel A Rodriguez; Wei Yang; Stephen Wong; Andreas Makris; Brian D Lehmann; Xi Chen; Ingrid Mayer; Jennifer A Pietenpol; Zhi-Ming Shao; W Fraser Symmans; Jenny C Chang Journal: Clin Cancer Res Date: 2013-04-02 Impact factor: 12.531
Authors: Salih Ozguven; Sabahat Inanir; Halil Turgut Turoglu; Tanju Yusuf Erdil; Mustafa Umit Ugurlu; Bahadir Gulluoglu Journal: Indian J Nucl Med Date: 2016 Jul-Sep